148 related articles for article (PubMed ID: 11493273)
1. Novel strategies for immortalization of human hepatocytes.
Cascio SM
Artif Organs; 2001 Jul; 25(7):529-38. PubMed ID: 11493273
[TBL] [Abstract][Full Text] [Related]
2. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
Kobayashi N; Okitsu T; Nakaji S; Tanaka N
J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte cell lines as the biological component of liver support.
Jauregui HO
Artif Organs; 2001 Jul; 25(7):509-12. PubMed ID: 11493270
[No Abstract] [Full Text] [Related]
4. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination.
Totsugawa T; Yong C; Rivas-Carrillo JD; Soto-Gutierrez A; Navarro-Alvarez N; Noguchi H; Okitsu T; Westerman KA; Kohara M; Reth M; Tanaka N; Leboulch P; Kobayashi N
J Hepatol; 2007 Jul; 47(1):74-82. PubMed ID: 17434229
[TBL] [Abstract][Full Text] [Related]
5. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices.
Liu J; Jauregui HO; Faris RA; Santangini HA; Trenkler DM; Silva PG; Garcia KM
Artif Organs; 2001 Jul; 25(7):539-45. PubMed ID: 11493274
[TBL] [Abstract][Full Text] [Related]
6. [Liver-targeted regenerative medicine].
Kobayashi N; Yong C; Tanaka N
Nihon Geka Gakkai Zasshi; 2004 Aug; 105(8):440-4. PubMed ID: 15373220
[TBL] [Abstract][Full Text] [Related]
7. Cre/loxP-based reversible immortalization of human hepatocytes.
Kobayashi N; Noguchi H; Westerman KA; Watanabe T; Matsumura T; Totsugawa T; Fujiwara T; Leboulch P; Tanaka N
Cell Transplant; 2001; 10(4-5):383-6. PubMed ID: 11549058
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
[TBL] [Abstract][Full Text] [Related]
9. Characterization of long-term survival of syngeneic hepatocytes in rat peritoneum.
Selden C; Casbard A; Themis M; Hodgson HJ
Cell Transplant; 2003; 12(6):569-78. PubMed ID: 14579925
[TBL] [Abstract][Full Text] [Related]
10. Amplification of engrafted hepatocytes by preparative manipulation of the host liver.
Guha C; Deb NJ; Sappal BS; Ghosh SS; Roy-Chowdhury N; Roy-Chowdhury J
Artif Organs; 2001 Jul; 25(7):522-8. PubMed ID: 11493272
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells.
Mashalova EV; Guha C; Roy-Chowdhury N; Liu L; Fox IJ; Roy-Chowdhury J; Horwitz MS
Hepatology; 2007 Mar; 45(3):755-66. PubMed ID: 17326202
[TBL] [Abstract][Full Text] [Related]
12. Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen.
Cai J; Ito M; Westerman KA; Kobayashi N; Leboulch P; Fox IJ
J Hepatol; 2000 Nov; 33(5):701-8. PubMed ID: 11097476
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.
Lee SW; Wang X; Chowdhury NR; Roy-Chowdhury J
Ann Hepatol; 2004; 3(2):48-53. PubMed ID: 15257246
[TBL] [Abstract][Full Text] [Related]
14. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
Kobayashi N
J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
[TBL] [Abstract][Full Text] [Related]
15. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy.
Tsuruga Y; Kiyono T; Matsushita M; Takahashi T; Kasai H; Matsumoto S; Todo S
Cell Transplant; 2008; 17(9):1083-94. PubMed ID: 19177844
[TBL] [Abstract][Full Text] [Related]
16. A Modified Protocol for the Isolation of Primary Human Hepatocytes with Improved Viability and Function from Normal and Diseased Human Liver.
Bartlett DC; Newsome PN
Methods Mol Biol; 2017; 1506():61-73. PubMed ID: 27830545
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte Transplantation in Children.
Coppin L; Sokal E; Stephenne X
Methods Mol Biol; 2017; 1506():295-315. PubMed ID: 27830562
[TBL] [Abstract][Full Text] [Related]
18. [Present status of gene-modified transplanted hepatocytes].
Lin Y; Zeng X; Xie WF
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):376-8. PubMed ID: 12837229
[No Abstract] [Full Text] [Related]
19. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes.
Cai J; Ito M; Nagata H; Westerman KA; Lafleur D; Chowdhury JR; Leboulch P; Fox IJ
Hepatology; 2002 Aug; 36(2):386-94. PubMed ID: 12143047
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor 4A improves hepatic differentiation of immortalized adult human hepatocytes and improves liver function and survival.
Hang HL; Liu XY; Wang HT; Xu N; Bian JM; Zhang JJ; Xia L; Xia Q
Exp Cell Res; 2017 Nov; 360(2):81-93. PubMed ID: 28870599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
